Drug Report, Erbitux- Drug Insights, 2016 highlights the Erbitux marketed details, pipeline status and the Global API Manufacturers along with the location. The report covers the Global Market Assessment of the Erbitux covering the total sales ... Research and Markets, 3 days ago
Global Erbitux Industry 2016-2021 Growth, Trends and Demands Research Report - Before It's News, 3 weeks ago
Erbitux-Drug Insights,2014 - Research and Markets, 1 month ago
2 images for "erbitux"
The All Wales Medicines Strategy Group has recommended Merck's Erbitux in combination with chemotherapy for restricted use in the NHS in Wales. Erbitux (cetuximab) is recommended for the first-line treatment of patients with RAS wild-type ...Pharmafile, 1 month ago Latest approvals for use of medicines in Scotland and Wales announced Good Health Suite, 3 weeks ago Cetuximab gets go ahead in Wales for mCRC patients Pharma Letter, 1 month ago
Eli Lilly and Co.'s 4Q15 Earnings Showed Growth of ~5% A look at Eli Lilly and Co. On January 28, 2016, Eli Lilly and Co. (LLY) reported an increase in its top line by ~5% in its 4Q15 earnings. The company met Wall Street analysts 4Q15 estimates ...Yahoo! Finance, 2 days ago Eli Lilly and Co.'s 4Q15 Business Segment Performance Yahoo! Finance, 3 hours ago Eli Lilly net profit moves up by 12% in Q4 PharmaBiz, 1 week ago Eli Lilly meets fourth-quarter expectations but trims '16 forecast MyInforms, 1 week ago
EurekAlert! provides embargoed and breaking science news you can't afford to miss. EurekAlert! offers a one-stop science news distribution service you can trust. EurekAlert! is a service of the American Association for the Advancement of Science. ...EurekAlert!, 23 hours ago
US-based biopharmaceutical company Sorrento Therapeutics (Sorrento) announced on 11 January 2016 that its partner, MabTech had successfully completed phase III clinical trials in China for STI-001, a copy biological for cetuximab (Erbitux) and ...GaBi Online, 1 day ago SORRENTO THERAPEUTICS : Announces Positive Data from Phase 3 studies of Biosimilar Antibodies, STI-001 and STI-002 4 Traders, 2 weeks ago Sorrento's RA biosimilar candidates successful in Phase III20-01-2016 Pharma Letter, 2 weeks ago Sorrento Announces Positive Data from Phase 3 studies of Biosimilar Antibodies, STI-001 and STI-002 Financial Content, 3 weeks ago
One of the most common posttranslational modifications of eukaryotic proteins is glycosylation. Glycosylation of proteins can affect many biological activities. For therapeutic glycoproteins, it can modify biological activity, targeting, ...BioProcess International, 1 day ago
Last year, over a million people in India were diagnosed with cancer. In the next 10 years, this number is expected to increase five times. The situation is not just alarming but frightening. As the world on Thursday observes Cancer Day, India needs ...Firstpost.com, 2 days ago
MOLECULAR PARTNERS : reports unaudited financial results for 2015: A year of substantial clinical progress in oncology
AD-HOC RELEASE Molecular Partners reports unaudited financial results for 2015: A year of substantial clinical progress in oncology R&D, Partnership and Team Highlights: Significant advancement of the company's proprietary pipeline in oncology, ...4 Traders, 2 days ago Molecular Partners reports unaudited financial results for 2015: A year of substantial clinical progress in oncology 4 Traders, 2 days ago
Kadmon founder Sam Waksal Kadmon , a biotech founded by once-jailed ImClone CEO Sam Waksal , is gearing up to test the waters for an IPO, according to CNBC , braving a brutal climate for drug developers on Wall Street after at least two previous ...FierceBiotech, 3 days ago Waksal's Kadmon said to plan IPO, without Waksal CNBC, 3 days ago
Source: Wikimedia CommonsIf you remember the dark days of 2009, then it may surprise you to know that currently Wall Street strategists and those who prognosticate the future are as bearish as they were then. In a new research note from Merrill ...24/7 Wall St, 4 days ago Merrill Lynch US 1 List On Sale: 4 Top Dividend Stocks to Buy Now 24/7 Wall St, 1 week ago Merrill Lynch US 1 List Has 4 Top-Yielding Dividend Stocks to Buy 24/7 Wall St, 1 month ago
on your WebpageAdd Widget >Get your members hooked!